This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May;17(5):4085-4093.
doi: 10.3892/ol.2019.9939. Epub 2019 Jan 16.

Photodynamic therapy: A hot topic in dermato-oncology

Affiliations
Review

Photodynamic therapy: A hot topic in dermato-oncology

Mircea Tampa et al. Oncol Lett. 2019 May.

Abstract

Photodynamic therapy (PDT) is a modern, non-invasive therapeutic method used for the destruction of various cells and tissues. It requires the simultaneous presence of three components: a photosensitizer (PS), a light source and oxygen. Precancerous skin lesions are conditions associated with a high likelihood of malignant transformation to squamous cell carcinoma. Data available so far indicate that PDT is a promising treatment method which can be successfully employed in several medical fields including dermatology, urology, ophthalmology, pneumology, cardiology, dentistry and immunology. Numerous authors therefore have studied this technique in order to improve its efficacy. As a result, significant advancement has been achieved with regard to PSs and drug delivery systems. Substantial progress was also obtained with respect to PDT for the treatment of precancerous skin lesions, several authors focusing their efforts on the study of daylight-PDT and on identifying methods of decreasing technique-related pain. This review reports on the most recent findings in PDT, with emphasis on cutaneous precancerous lesions.

Keywords: actinic cheilitis; actinic keratosis; photodynamic therapy; precancerous lesions; squamous cell carcinoma.

PubMed Disclaimer

References

    1. Benov L. Photodynamic therapy: Current status and future directions. Med Princ Pract. 2015;24(Suppl 1):14–28. doi: 10.1159/000362416. - DOI - PMC - PubMed
    1. Braathen LR, Morton CA, Basset-Seguin N, Bissonnette R, Gerritsen MJ, Gilaberte Y, Calzavara-Pinton P, Sidoroff A, Wulf HC, Szeimies RM, International Society for Photodynamic Therapy in Dermatology Photodynamic therapy for skin field cancerization: An international consensus. J Eur Acad Dermatol Venereol. 2012;26:1063–1066. doi: 10.1111/j.1468-3083.2011.04432.x. - DOI - PubMed
    1. Matei C, Tampa M, Caruntu C, Ion RM, Georgescu SR, Dumitrascu GR, Constantin C, Neagu M. Protein microarray for complex apoptosis monitoring of dysplastic oral keratinocytes in experimental photodynamic therapy. Biol Res. 2014;47:33. doi: 10.1186/0717-6287-47-33. - DOI - PMC - PubMed
    1. Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV. Nanodrug applications in photodynamic therapy. Photodiagn Photodyn Ther. 2011;8:14–29. doi: 10.1016/j.pdpdt.201012001. - DOI - PubMed
    1. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick's Dermatology in General Medicine. 8th. McGrawHill; New York: 2012. Epidermal and appendageal tumors; pp. 1007–1094.
Cite

AltStyle によって変換されたページ (->オリジナル) /